1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TMEM53 CTRPv2 pan-cancer AAC 0.092 0.009
mRNA FAM188A CTRPv2 pan-cancer AAC -0.091 0.01
mRNA RNFT2 CTRPv2 pan-cancer AAC -0.098 0.01
mRNA SCLT1 CTRPv2 pan-cancer AAC -0.092 0.01
mRNA NAP1L5 CTRPv2 pan-cancer AAC -0.1 0.01
mRNA PRCD CTRPv2 pan-cancer AAC 0.13 0.01
mRNA MT-CO2 CTRPv2 pan-cancer AAC 0.1 0.01
mRNA XRCC2 CTRPv2 pan-cancer AAC -0.098 0.01
mRNA OMP CTRPv2 pan-cancer AAC 0.097 0.01
mRNA MIA CTRPv2 pan-cancer AAC 0.11 0.01
Download CSV